Trends in Hospital Inpatient Drug Costs: Issues and Challenges

October 11, 2016

AHA also released an infographic outlining how rising drug prices are hurting hospitals and potentially limiting access to care for patients.

Key Resources

Related Resources

Guides/Reports
Massive Growth in Expenses & Rising Inflation Fuel Financial Challenges for America’s Hospitals & Health Systems
A new AHA report highlights the significant growth in expenses across labor, drugs, and supplies, as well as the impact that rising inflation is having on…
Guides/Reports
Costs of Caring
Public
Hospitals appreciate the support and resources that Congress have provided throughout the COVID-19 pandemic; however, additional support is needed to keep…
Testimony
AHA Senate Statement: “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare”
Public
AHA shares proposals to lower Medicare drug prices with congress.
AHA Center for Health Innovation Market Scan
Civica Rx Aims to Disrupt Generic Insulin Market Pricing by 2024
Pending federal approval, Civica Rx, the nonprofit consortium of U.S. hospitals, plans to manufacture and distribute several generic insulins, continuing its…
AHA Center for Health Innovation Market Scan
Will Startup PBMs Drive Drug Price Transparency?
The Purchaser Business Group on Health (PBGH), a coalition of about 40 large private and public employers including Walmart, Disney, Costco and Microsoft,…
AHA Center for Health Innovation Market Scan
Walmart, Transcarent Team Up to Woo Self-Insured Employers
Walmart recently partnered with the consumer-facing health care platform Transcarent to provide low-cost prescription drugs, telehealth, optical and other…